ResearcherTianjin University of Traditional Chinese MedicineNo recent work listed

Hongfeng Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4646-0515; OpenAlex author ID A5100615432. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2023: 1 paper

Papers 1

EZH2 regulates pancreatic cancer cells through E2F1, GLI1, CDK3, and Mcm4. Co-author DOI 10.1186/s41065-023-00280-1 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Pengfei Liu · 1 shared paper, 2023 · strength 0.16
- Paper EZH2 regulates pancreatic cancer cells through E2F1, GLI1, CDK3, and Mcm4. DOI 10.1186/s41065-023-00280-1 ↗
Kuo Zhao · 1 shared paper, 2023 · strength 0.16
- Paper EZH2 regulates pancreatic cancer cells through E2F1, GLI1, CDK3, and Mcm4. DOI 10.1186/s41065-023-00280-1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.